About Haermonics
Haermonics is a company based in Amsterdam (Netherlands) founded in 2015. Haermonics has raised $4.41 million across 1 funding round from investors including BOM, Demcon and Invest-NL. Haermonics offers products and services including Haermonics Laebroides. Haermonics operates in a competitive market with competitors including Haemonetics, VISIE, Sisu Global Health, Scinovia and ProCell, among others.
- Headquarter Amsterdam, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.41 M (USD)
in 1 rounds
-
Latest Funding Round
$4.41 M (USD), Series A
Aug 02, 2022
-
Investors
BOM
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Haermonics
Haermonics offers a comprehensive portfolio of products and services, including Haermonics Laebroides.
Device for flushing pericardial space to prevent post-operative complications.
Funding Insights of Haermonics
Haermonics has successfully raised a total of $4.41M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.41 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Haermonics
Haermonics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include BOM, Demcon and Invest-NL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed by BOM toward early and growth-stage firms.
|
Locked | Locked | Locked | |
|
Infrastructure and venture capital funding is provided in key sectors.
|
Locked | Locked | Locked | |
|
Health innovations are found, built, and scaled by NLC.
|
Locked | Locked | Locked |
Investor details for Haermonics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Haermonics
Investment portfolio details for Haermonics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Haermonics
Detailed financials for Haermonics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Haermonics Comparisons
Peer comparison for Haermonics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Haermonics
Haermonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, VISIE, Sisu Global Health, Scinovia and ProCell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hematology products and solutions are provided for medical applications.
|
|
| Locked | Locked | Locked |
Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery
|
|
| Locked | Locked | Locked |
Intraoperative autotransfusion devices are developed and provided.
|
|
| Locked | Locked | Locked |
Augmented-reality surgical cameras for blood flow visualization are developed.
|
|
| Locked | Locked | Locked |
Develops medical devices for intraoperative blood recovery and conservation.
|
Detailed competitors of Haermonics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Haermonics
Complete news archive for Haermonics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Haermonics
Haermonics was founded in 2015 and raised its 1st funding round 7 years after it was founded.
Haermonics is headquartered in Amsterdam, Netherlands.
Haermonics is a funded company, having raised a total of $4.41M across 1 funding round to date.
Harmonics has developed a drainage and flushing system that allows the implementation of continuous postoperative pericardial flushing. It allows a controlled infusion of a warmed liquid solution into the pericardial cavity after the operation while the system monitors blood loss. Continuous flushing will result in a lower viscosity mixture that will prevent chest tubes from clogging and promote the evacuation of blood and clots from the pericardial cavity.
Haermonics's top competitors include Haemonetics, VISIE and Sisu Global Health.
Haermonics offers Haermonics Laebroides.
Haermonics has 4 investors. Key investors include BOM, Demcon, Invest-NL, and NLC Health Ventures.